2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole

C292H280N36O4 — CID 158638182

About 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole

2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole (PubChem CID 158638182) has the molecular formula C292H280N36O4 and a molecular weight of 4357.70 g/mol. Its IUPAC name is 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole.

Molecular Properties

• Compound Name: 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole
• PubChem CID: 158638182
• Molecular Formula: C292H280N36O4
• Molecular Weight: 4357.70 g/mol
• Exact Mass: 4354.28
• IUPAC Name: 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole
• SMILES: CC1(C)CN=C(c2ccc(-c3nc(-c4ccc(C5=NCC(C)(C)O5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)O1.CC1(C)N=C(c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(C5=NC(C)(C)C(C)(C)O5)c4)n3)c2)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2ccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)cc4)n3)cc2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)cc4)n3)cc2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C
• InChI: InChI=1S/2C54H52N6.2C53H51N7.C41H41N5O2.C37H33N5O2/c1-51(2)53(5,6)59(49(57-51)40-22-14-10-15-23-40)44-28-18-26-42(34-44)47-36-46(39-32-30-38(31-33-39)37-20-12-9-13-21-37)55-48(56-47)43-27-19-29-45(35-43)60-50(41-24-16-11-17-25-41)58-52(3,4)54(60,7)8;1-51(2)53(5,6)59(49(57-51)42-20-14-10-15-21-42)44-32-28-40(29-33-44)47-36-46(39-26-24-38(25-27-39)37-18-12-9-13-19-37)55-48(56-47)41-30-34-45(35-31-41)60-50(43-22-16-11-17-23-43)58-52(3,4)54(60,7)8;1-50(2)52(5,6)59(48(57-50)39-22-14-10-15-23-39)43-28-18-26-41(34-43)46-54-45(38-32-30-37(31-33-38)36-20-12-9-13-21-36)55-47(56-46)42-27-19-29-44(35-42)60-49(40-24-16-11-17-25-40)58-51(3,4)53(60,7)8;1-50(2)52(5,6)59(48(57-50)41-20-14-10-15-21-41)43-32-28-39(29-33-43)46-54-45(38-26-24-37(25-27-38)36-18-12-9-13-19-36)55-47(56-46)40-30-34-44(35-31-40)60-49(42-22-16-11-17-23-42)58-51(3,4)53(60,7)8;1-38(2)40(5,6)47-36(45-38)31-18-12-16-29(24-31)34-42-33(28-22-20-27(21-23-28)26-14-10-9-11-15-26)43-35(44-34)30-17-13-19-32(25-30)37-46-39(3,4)41(7,8)48-37;1-36(2)22-38-34(43-36)29-18-14-27(15-19-29)32-40-31(26-12-10-25(11-13-26)24-8-6-5-7-9-24)41-33(42-32)28-16-20-30(21-17-28)35-39-23-37(3,4)44-35/h2*9-36H,1-8H3;2*9-35H,1-8H3;9-25H,1-8H3;5-21H,22-23H2,1-4H3
• InChIKey: IAANGDXAPQUNTH-UHFFFAOYSA-N
• XLogP: 66.82
• TPSA: 417.40 Ų
• H-Bond Acceptors: 40
• Rotatable Bonds: 44
• Heavy Atoms: 332
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	4357.70
LogP ≤ 5	66.82
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	40

Frequently Asked Questions

What is the IUPAC name of 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole?

The IUPAC name of 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole (CID 158638182) is 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole.

What is the SMILES notation for 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole?

The canonical SMILES for 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole is CC1(C)CN=C(c2ccc(-c3nc(-c4ccc(C5=NCC(C)(C)O5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)O1.CC1(C)N=C(c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(C5=NC(C)(C)C(C)(C)O5)c4)n3)c2)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2ccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)cc4)n3)cc2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)cc4)n3)cc2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C.

What is the InChIKey of 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole?

The InChIKey is IAANGDXAPQUNTH-UHFFFAOYSA-N. The full InChI is InChI=1S/2C54H52N6.2C53H51N7.C41H41N5O2.C37H33N5O2/c1-51(2)53(5,6)59(49(57-51)40-22-14-10-15-23-40)44-28-18-26-42(34-44)47-36-46(39-32-30-38(31-33-39)37-20-12-9-13-21-37)55-48(56-47)43-27-19-29-45(35-43)60-50(41-24-16-11-17-25-41)58-52(3,4)54(60,7)8;1-51(2)53(5,6)59(49(57-51)42-20-14-10-15-21-42)44-32-28-40(29-33-44)47-36-46(39-26-24-38(25-27-39)37-18-12-9-13-19-37)55-48(56-47)41-30-34-45(35-31-41)60-50(43-22-16-11-17-23-43)58-52(3,4)54(60,7)8;1-50(2)52(5,6)59(48(57-50)39-22-14-10-15-23-39)43-28-18-26-41(34-43)46-54-45(38-32-30-37(31-33-38)36-20-12-9-13-21-36)55-47(56-46)42-27-19-29-44(35-42)60-49(40-24-16-11-17-25-40)58-51(3,4)53(60,7)8;1-50(2)52(5,6)59(48(57-50)41-20-14-10-15-21-41)43-32-28-39(29-33-43)46-54-45(38-26-24-37(25-27-38)36-18-12-9-13-19-36)55-47(56-46)40-30-34-44(35-31-40)60-49(42-22-16-11-17-23-42)58-51(3,4)53(60,7)8;1-38(2)40(5,6)47-36(45-38)31-18-12-16-29(24-31)34-42-33(28-22-20-27(21-23-28)26-14-10-9-11-15-26)43-35(44-34)30-17-13-19-32(25-30)37-46-39(3,4)41(7,8)48-37;1-36(2)22-38-34(43-36)29-18-14-27(15-19-29)32-40-31(26-12-10-25(11-13-26)24-8-6-5-7-9-24)41-33(42-32)28-16-20-30(21-17-28)35-39-23-37(3,4)44-35/h2*9-36H,1-8H3;2*9-35H,1-8H3;9-25H,1-8H3;5-21H,22-23H2,1-4H3.

What are the key properties of 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole?

2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole has a molecular weight of 4357.70 g/mol, XLogP of 66.82, 44 rotatable bonds, 0 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4-[4-[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;4-(4-phenylphenyl)-2,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;4-(4-phenylphenyl)-2,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]pyrimidine;2-(4-phenylphenyl)-4,6-bis[3-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;2-(4-phenylphenyl)-4,6-bis[4-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)phenyl]-1,3,5-triazine;4,4,5,5-tetramethyl-2-[3-[4-(4-phenylphenyl)-6-[3-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-oxazole is sourced from PubChem (CID 158638182), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).